Trends in European Disposable E-cigarette Market's New Flavors

Apr.27.2023
Trends in European Disposable E-cigarette Market's New Flavors
2FIRSTS analyzes European e-cigarette market trends through multiple perspectives, revealing new flavor trends and growth in disposable e-cigarettes.

Recently, 2FIRSTS conducted a comprehensive analysis of the European e-cigarette market, focusing on dimensions such as flavor, company, brand, e-liquid, and appearance. This analysis was based on official information from important logistics centers in Europe. By utilizing multiple perspectives, 2FIRSTS was able to gain insight into the future trends of the European e-cigarette market.


Official data released shows that in March, there were 319 new electronic cigarette products introduced in Europe. Disposable e-cigarettes accounted for over 85% of these new products, while pod-based e-liquids and cartridge-based e-liquid kits made up 9.6% and 7.2%, respectively.


2FIRSTS has conducted an in-depth analysis of the European disposable e-cigarette market's new flavor trends from a flavor standpoint, based on this "incremental data." The data shows that the most prominent growth occurred in grape ice, watermelon ice, strawberry ice, and mango peach flavors. Mixed fruit flavors also saw an increase, including strawberry banana, strawberry, blueberry, and cherry blends, as well as kiwi passion fruit guava. Mixed berries had the largest increase, growing 10.7% year-over-year.


It is expected that by October 2023, the aforementioned flavors will become the new flavors with the highest increase in market volume in the European Bai Guan market.


Image: Distribution of mixed flavors of new electronic cigarette products in April | Data source: European Health Department whitelist, 2FIRSTS Note: The above chart only counts the number of times various flavor keywords appear simultaneously. If it is a mixed flavor of three flavors, it will be counted once in each of the two flavors.


Furthermore, there has been a significant increase in flavors such as pineapple, banana, guava, peach, mango, and grape, all with growth rates exceeding 8%. (Note: This increase refers to all flavors containing the respective fruit, including mixed fruit flavors.)


Incremental Contribution Ratio | Image source: 2FIRSTS exclusive compilation. The chart is derived from the free website http://www.flaticon.com.


2FIRSTS will continue to report on research and analysis of the European e-cigarette market. Stay tuned for updates.


The data and images in this article were compiled by 2FIRSTS based on the e-cigarette whitelist published by Belgium. Belgium is an important logistics hub in Europe, with Brussels Airport being a key port for Chinese e-cigarettes to set sail. Additionally, Belgium has established a free trade zone called Benelux with the Netherlands and Luxembourg, allowing for free flow of goods within the trade zone. Belgium requires all imported and manufactured products to be registered and recorded on their "whitelist" six months before being placed on the market. This whitelist is published by the Federal Public Service of Health, Environment and Food Chain Safety in Belgium (FPS Public Health).


Further reading:


According to a market research by 2FIRSTS, narrowing of electronic cigarette flavors is an inevitable trend as the market moves towards further segmentation.


2FIRSTS Market Research: Only Accepting White Labels and Forced Transformation - How is the Russian E-Cigarette Market Doing Under Strong Regulatory Signals?


What impact has the "e-liquid exceeding standards" incident had on the electronic cigarette distributors in Manchester, UK?


2FIRSTS recently interviewed the electronic cigarette brand Fume, which claims to be the first in Florida. The company is currently developing a new hybrid flavor.


A survey conducted by 2FIRSTS on the appearance of electronic cigarettes in Europe found that black, blue, and red are the most popular colors, while green and pink are experiencing the fastest growth.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's parliament is scheduled to hold a first reading of amendments to the Tobacco Tax Act on September 24. The government plans annual tax increases from 2027 through 2030 covering cigarettes, heated tobacco, vaping liquids and other categories. It expects the reform to generate €756 million in additional revenue in 2027, rising to €3.589 billion in additional annual revenue by 2030. Ahead of the parliamentary debate, the German Association of the Tobacco Industry and Novel Products, or BVTE, launched the "Tabaksteuer mit Augenmaß" campaign backed by BAT, JTI, Philip Morris, Reemtsma and wholesale and retail groups.
Sep.23
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25